Prelude Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | +73.4% | |
| – | +156.4% | +41.9% | +313.8% | +35.6% | -61.6% | +51.6% | -3.4% | |
| – | – | – | – | – | – | – | +49.0% | |
| – | +92.4% | +98.4% | +80.1% | +7.0% | +11.3% | +14.1% | -20.1% | |
| – | +62.7% | +176.4% | +154.6% | +13.7% | -5.8% | -0.6% | -22.0% | |
| – | +87.7% | +109.1% | +93.5% | +8.6% | +7.1% | +10.9% | -21.6% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | -35.1% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | -28.8% | +59.8% | -372.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.